ARQT Congressional Stock Trades
Arcutis Biotherapeutics, Inc. - Common stock (ARQT)
Last disclosed trade Sep 15
Every disclosed trade in ARQT by members of Congress under the STOCK Act, parsed by Coldpine. Informational only, sourced from public filings. Not investment advice.
Sample · the intelligence layer
Josh Gottheimer · Bought $ARQT · Apr 17 · $1K–$15K
Managed-account penalty applied (x 0.20): filings dominated by trust or wealth-manager activity are discounted.
Every disclosed trade in the database gets this treatment: a four-factor score and a written read from Coldpine’s AI-based analysis. Informational only, not investment advice. Create a free account for every scored trade →
Follow $ARQT
Get notified when any member of Congress trades $ARQT. Free, no card, no spam.
The record on $ARQT
Coldpine has parsed 2 disclosed trades in $ARQT by 1 member of Congress, drawn from 2 periodic transaction reports dated Apr 17, 2023 through Sep 15, 2023. All of them came from House members, all filed by Democrats.
Of the 2 trades with a known filing lag, every one was reported inside the STOCK Act's 45-day window. The median lag was 31 days. The longest was 32 days: a $ARQT purchase by Josh Gottheimer dated Apr 17, 2023, disclosed May 19, 2023. How late filing is measured across all of Congress is in the late-filers study.
2 of the 2 trades that list an account holder (100%) were reported under a spouse, dependent child, or joint account rather than the member directly.
Members who trade ARQT
Recent disclosed trades in ARQT
| Date | Member | Type | Amount |
|---|---|---|---|
| Sep 15 | Josh Gottheimer(NJ) | sell | $1K–$15K |
| Apr 17 | Josh Gottheimer(NJ) | buy | $1K–$15K |
Data sourced from public STOCK Act disclosures. Coldpine is a publisher of intelligence on congressional disclosures, not an investment adviser. See full history and scores, free with an account →